More articles from Review

  • Prostate cancer: current concepts in diagnosis and treatment
    Eric A. Klein, MD
    Cleveland Clinic Journal of Medicine July 1992, 59 (4) 383-389;

    Controversy persists over how best to screen the general population for prostate cancer, and whether earlier detection decreases mortality. The author outlines an approach to screening, diagnosis, and treatment grounded on A U A guidelines and clinical experience.

  • Doppler echocardiographic assessment of aortic regurgitation: uses and limitations
    Allan L. Klein, MD, Malcolm B. Davison, MBBS, Galen Vonk, MD and A. Jamil Tajik, MD
    Cleveland Clinic Journal of Medicine July 1992, 59 (4) 359-368;

    The final determination of the severity of aortic regurgitation should involve a combination of the various Doppler techniques and the indices derived from them.

  • Gardner’s hydrodynamic theory of syringomyelia revisited
    Prem K. Pillay, MD, Issam A. Awad, MD, MSc and Joseph F. Hahn, MD
    Cleveland Clinic Journal of Medicine July 1992, 59 (4) 373-380;

    How longitudinal, fluid-filled cavities form within the spinal cord has eluded researchers, though widely espoused theories have been put forth. The authors propose a unified theory based on recent MRI experience and on elements of other current theories.

  • Viral hepatitis in the 1990s, part II: hepatitis B and delta virus
    William D. Carey, MD and Glrish Patel, MD
    Cleveland Clinic Journal of Medicine July 1992, 59 (4) 393-401;

    Effective vaccines are available. High-risk groups have been identified. But widespread prevention of hepatitis B infection remains an elusive goal, and key questions need answers: What are the mechanisms of transmission, including mother-to-offspring transmission? What short - and long-term risks do health care professionals face?

  • Pharmacotherapy of multiple sclerosis: current status
    Richard A. Rudick, MD, Donald E. Goodkin, MD and Richard M. Ransohoff, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 267-277;

    With careful drug selection and close monitoring, many symptoms associated with MS are effectively controlled.

  • Doppler echocardiographic assessment of constrictive pericarditis, cardiac amyloidosis, and cardiac tamponade
    Allan L. Klein, MD and Gerald I. Cohen, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 278-290;

    Doppler echocardiography is emerging as an excellent noninvasive way to assess diastolic function, and its array of clinical applications is expanding.

  • Lung and heart-lung transplantation: the state of the art
    Patrick M. McCarthy, MD, Thomas J. Kirby, MD, Richard D. White, MD, Thomas W. Rice, MD, Eliot R. Rosenkranz, MD, Andrea P. Baldyga, MD, Rita Vargo, RN and Atul C. Mehta, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 307-316;

    Lung and heart-lung transplantation is no longer experimental, but a reasonable option in many heart and lung disorders previously deemed fatal.

  • Primary angiitis of the central nervous system: diagnostic criteria and clinical approach
    Leonard H. Calabrese, DO, Anthony J. Furlan, MD, Lisa A. Gragg, MS and Trumane J. Ropos, DO
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 293-306;

    Clinical perceptions of PACNS have changed dramatically in the last 5 years, prompting a reappraisal of the 1987 diagnostic criteria and current approaches to treatment

  • Viral hepatitis in the 1990s, part I: current principles of management
    William D. Carey, MD and Girish Patel, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 317-325;

    An update of the clinical management of viral hepatitis, based on recent developments in screening and diagnosis.

  • Survivors of sudden cardiac death: a rational approach to evaluation and therapy of patients surviving ventricular fibrillation
    Arthur J. Rabinowitz, MD and James D. Maloney, MD
    Cleveland Clinic Journal of Medicine March 1992, 59 (2) 166-172;

    A strategy for identifying underlying disease, stratifying the risk of recurrence, and formulating specific therapy in these patients, at high risk for life-threatening ventricular tachyarrhythmias.

Pages